Literature DB >> 19744886

The role of specific Toxoplasma gondii molecules in manipulation of innate immunity.

Angela M Pollard1, Laura J Knoll, Dana G Mordue.   

Abstract

Infection with the parasite Toxoplasma gondii stimulates an innate immune response in the host. T. gondii also induces alterations in infected monocytes and dendritic cells that probably contribute to its ability to disseminate and ultimately to establish persistent infection. Recent progress has linked specific parasite molecules to immune stimulation or the ability of the parasite to subvert intracellular signaling pathways in infected cells to evade immunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19744886      PMCID: PMC2771455          DOI: 10.1016/j.pt.2009.07.009

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  26 in total

1.  Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha.

Authors:  C G Lüder; W Walter; B Beuerle; M J Maeurer; U Gross
Journal:  Eur J Immunol       Date:  2001-05       Impact factor: 5.532

Review 2.  From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii.

Authors:  Eric Y Denkers
Journal:  FEMS Immunol Med Microbiol       Date:  2003-12-05

Review 3.  Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma gondii.

Authors:  Julio Aliberti
Journal:  Nat Rev Immunol       Date:  2005-02       Impact factor: 53.106

Review 4.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

Review 5.  Cellular responses to interferon-gamma.

Authors:  U Boehm; T Klamp; M Groot; J C Howard
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

6.  IL-10-independent STAT3 activation by Toxoplasma gondii mediates suppression of IL-12 and TNF-alpha in host macrophages.

Authors:  Barbara A Butcher; Leesun Kim; Athanasia D Panopoulos; Stephanie S Watowich; Peter J Murray; Eric Y Denkers
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

7.  Virulent strains of Toxoplasma gondii comprise a single clonal lineage.

Authors:  L D Sibley; J C Boothroyd
Journal:  Nature       Date:  1992-09-03       Impact factor: 49.962

8.  Production of IL-12 by macrophages infected with Toxoplasma gondii depends on the parasite genotype.

Authors:  Paul M Robben; Dana G Mordue; Steven M Truscott; Kiyoshi Takeda; Shizuo Akira; L David Sibley
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

Review 9.  Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence.

Authors:  Ira J Blader; Jeroen P Saeij
Journal:  APMIS       Date:  2009-05       Impact factor: 3.205

10.  CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection.

Authors:  Imtiaz A Khan; Seddon Y Thomas; Magali M Moretto; Frederick S Lee; Sabina A Islam; Crescent Combe; Joseph D Schwartzman; Andrew D Luster
Journal:  PLoS Pathog       Date:  2006-06-09       Impact factor: 6.823

View more
  12 in total

1.  Toxoplasma gondii cyclophilin 18 regulates the proliferation and migration of murine macrophages and spleen cells.

Authors:  Hany M Ibrahim; Xuenan Xuan; Yoshifumi Nishikawa
Journal:  Clin Vaccine Immunol       Date:  2010-07-21

2.  UNC93B1 is essential for TLR11 activation and IL-12-dependent host resistance to Toxoplasma gondii.

Authors:  Reed Pifer; Alicia Benson; Carolyn R Sturge; Felix Yarovinsky
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

3.  Toxoplasma gondii upregulates interleukin-12 to prevent Plasmodium berghei-induced experimental cerebral malaria.

Authors:  Erik W Settles; Lindsey A Moser; Tajie H Harris; Laura J Knoll
Journal:  Infect Immun       Date:  2014-01-06       Impact factor: 3.441

4.  Toxoplasma on the brain: understanding host-pathogen interactions in chronic CNS infection.

Authors:  Sushrut Kamerkar; Paul H Davis
Journal:  J Parasitol Res       Date:  2012-03-22

5.  Strain-dependent host transcriptional responses to Toxoplasma infection are largely conserved in mammalian and avian hosts.

Authors:  Yi-Ching Ong; Jon P Boyle; John C Boothroyd
Journal:  PLoS One       Date:  2011-10-13       Impact factor: 3.240

6.  Gene expression profiles in genetically different mice infected with Toxoplasma gondii: ALDH1A2, BEX2, EGR2, CCL3 and PLAU.

Authors:  Hassan Ahmed Hassan Ahmed Ismail; Juan-Hua Quan; Zhou Wei; In-Wook Choi; Guang-Ho Cha; Dae-Whan Shin; Young-Ha Lee; Chang-June Song
Journal:  Korean J Parasitol       Date:  2012-03-06       Impact factor: 1.341

7.  Virulent and avirulent strains of Toxoplasma gondii which differ in their glycosylphosphatidylinositol content induce similar biological functions in macrophages.

Authors:  Sebastian Niehus; Terry K Smith; Nahid Azzouz; Marco A Campos; Jean-François Dubremetz; Ricardo T Gazzinelli; Ralph T Schwarz; Françoise Debierre-Grockiego
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

8.  Development of 116 kDa Fraction for Detecting Experimental Toxoplasma gondii Infections in Mice.

Authors:  Mohey Abdel-Hafez Hassanain; Eman Hussien Abdel-Rahman; Nagwa Ibrahim Toaleb; Raafat Mohamed Shaapan; Hasan Ali Elfadaly; Nawal Abdel-Hafez Hassanain
Journal:  Iran J Parasitol       Date:  2013-07       Impact factor: 1.012

Review 9.  Use and abuse of dendritic cells by Toxoplasma gondii.

Authors:  Anna Sanecka; Eva-Maria Frickel
Journal:  Virulence       Date:  2012-11-15       Impact factor: 5.882

10.  SAG2A protein from Toxoplasma gondii interacts with both innate and adaptive immune compartments of infected hosts.

Authors:  Arlindo G Macêdo; Jair P Cunha; Thyago H S Cardoso; Murilo V Silva; Fernanda M Santiago; João S Silva; Carlos P Pirovani; Deise A O Silva; José R Mineo; Tiago W P Mineo
Journal:  Parasit Vectors       Date:  2013-06-05       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.